A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)

NCT01860729 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

589

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Anacetrapib
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC